Many cases of vaccine damage couldhave been prevented if the vaccinehad been avoided after a bad reactionto the previou one. In many severeca e we could detect a bad reactionto the previou vaccine.In children with any su pected neuro-logical damage (hypotonia, slow de-velopment, difficult delivery, etc.),postponing vaccination is important.The possibility of forgoing them com-pletely should also be considered.When one child in the family has suf-

Meningococcinum

fered some vaccine damage, greatercare must be taken with the otherchildren. W/e try to postpone vaccinat-ing them as long as po ible.If the child eem to be uffering fromvaccine damage, homeopathic helpshould be sought immediately.In any case of disease developing dur-ing the first year of life, especially ifthe child i till nursing, the possibilityof vaccine damage hould be checkedcarefully.\X'e do not recommend new vaccines

VACCI AT/O

like Hepatitis-A and Vermicelli.If there is an outbreak of a local epi-demic and the child has not been vac-cinated, the child hould be taken tothe attending homeopath and given ahomeopathic vaccine.

Dr. Chaim RosenthalDirector of rhe Israeli School Of HomeoparhyFax: +972-3-6429743or +972-9-7741695Email: homeoroj.allel"visioll.ller.il

Its protective effect against meningococcal disease

C.R.L. Mroninski, E.J. Adriano, G. Mattos, Brazil

SummaryMellillgococcal disease (MD) is srill a bigchallenge to public healrh, judgillg by irsmorraliry rare, from 10 to 12~0, as well as irssequels seldom 1I0r drama ric. The prevenrivemechanisms like rhe available vaccines,lIowadays, do 1I0r preselll ellough ejfecrive-lIess £0 reassure rhe healrh mallagers alld rhepopularion when rhey face rhe illcrease of rhecases epidemiological siglllficGIll. The aClllalwork relares rhe use of rhe 1I0sode Nlellillgo-coccillum 30 CH 011 people from 0 to 20years of age ill Blumenau, Brazil, ill 1998.The results were slarisrically siglllficalll, of-

ferillg a prorecrioll agaillSr ,HD of 9500 ill

six mOlllhs alld 91% in a year.

Introduction

Meningococcal infection occur endemi-cally and epidemically and are the bigge tcau e of mortality and morbidity in de-veloped and in underdeveloped coun-trie. Meningococcal meningitis i thetype of m meningococcal disease (MD),that has been the most common cause ofbacterial meningitis in children in theUnited State, ince the project of immu-ni ing for Haemophilus illjluellzae type b,initiated in the eightie, reduced thimo t prevalent pathology dramatically.The rate of mortality from meningococ-cal meningiti i approximately ten totwelve percent. It occurs ten times morein children up to two years of age than inthe remainder of the population, withoutsex preference. Its pathogenic perfor-

mance al 0 remain considerable in adultlife, when it tart to be the econd mo tfrequent type, econd only to pneumo-coccal meningiti (I).

The deva tating nature of the ystemicmeningococcal infection make it imper-ative that preventive steps are developedfor ample control of this disease, how-ever, an effective \"accine is not still devel-oped again t meningococcal infection ofthe erum type B (1). Nowadays there isa vaccine against MD of the types A andC, however, despite the great efforts todevelop a vaccine again t erum type B,have not been ucce ful. Attempt havebeen tried in Cuba and Brazil, with aglobal effectivene s of 50 to 90%, butwith little effectivene in children (2). Asthe meningococcal vaccine ha limitedeffectivene in the group at high-risk forinfections - children below two years ofage - meningococcal infection is still thebiggest, worldwide, health problem (I).To that dramatic problem, we believethat homeopathy has a contribution togive, based on a more than 200 year his-tory of therapeutics, and with impressivestorie from the field of public health inthe control of different types of epidemicdi ea es.

Thi work aim to contribute to thi hi-tory, telling about the use of Meningococ-cinum 30 CH in the City of Blumenau,Brazil, in the year 198 .

The city

The city of Blumenau is situated in thenorth of Santa Catarina State, known a the'European Valley' because it is populatedmainly by Europeans, e pecially German .It has a population e timated at 240.302 in-habitants. Its main characteristic is that it issituated in a mountainous region and iscrossed by a river, the Itajai-afi:u River. It isa city where people only sleep and live,while they work in an industrial area ofmainly the textile industry. In a similar way,there is a considerable flow of people whorelocate from those citie to Blumenauseeking medical help of deeper complexity.

The problem

According to the data given through theEpidemiological Vigilance of the state ofSanta Catarina, meningococcal meningitisis an endemic disea e in the state. Sincethe epidemic that occurred in 19 6, theincidence icon i tently above of the ex-pected levels, with peaks in 19 9 and1995. Both in the epidemics and in the in-cidence that are observed in tile state av-erage, the city of Blumenau ha a higherincidence than other citie . (Chartl)In 1998, ix ca e of MD had occurred byMay, one being a fatal ca e in a child ofix months of age. The age of the cases

varied between four months and nineteenyears of age. All of them had meningococ-cal meningitis, but one of the cases pre-sented meningococcemia.

230 Homreopathic Links, Winter 2001, Vol. 14 (4)

VACCI AT/O

Chart 2: Distribution of the population ill Blumenau from 0 to 20(incomplete) years of ageas having or not received the homeopathic medication and if there was DM after during thepost-immunisation period. aune 12 to December 31, 1998).

Chart 1: umber of cases and incidence of Meningococcal Disease In Blumenau andSanta Catarina, Brazil.

There was an announcement by the preregarding the offer of the medication avail-able at the health stations. On the day ofthe immuni ation, it was reported that themedical colleague who work at the Hos-

teen minutes before preparative by thehomeopathic method, and tested in thematrice 6 CH and 28 CH by the Micro-biology Department at the University ofSao Paulo ( SP). The medication wasnon-obligatorily offered to the populationaged zero to twenty years of age, in Blu-menau. One drop of l'v1ellillgococcinllm 30CH was given orally to those who volun-tarily came to the health units. /\'IIX vomica6 CH wa utilized as a homeo-antidote forpo ible ide effect.

Total

The results

pita I Emergency W'ard had bottles of Nux!-bmica available, and with them po sibleide effects could be di cu ed. Thi was

offered to the colleagues along with amedical homeopath for phone contacts, ifnecessary.The name, age and neighborhood of eachimmunised per on wa recorded, 0 thatwe later could compare the name of thecases of MD with the name on thi Ii t.Register on the Official Vaccination Cardwas not made because the no ode is notconsidered a vaccine, despite its immuni-sation power.

The population for Blumenau in 199 ,aged between zero and twenty years of agei 89.365 people (incomplete) as esti-mated by IBGE - the Brazilian Institute ofGeography and Statistics, from the cen usof 1996. A 65.826 per ons were regis-tered a ha\'ing received the nosode, it waestimated that the population that did notreceive it was about 23.532 per on .Analysing chart 2, 73,65% of this targetpopulation received the no ode.As the immuni ation happened in themiddle of 199 , in June, let' fir t analy e,using chart 2, the impact of the immuni-sation that year. There were fourteen casesof DM in Blumenau, in 1998. Eight oftho e ca e , or 57%, occurred after theimmuni ation. Among those eight cases,only one of them received the medication.That case wa a three-month-old childwho was diagnosed about forty days afterthe beginning of the campaign. Duringthat year, one patient died before the im-

Did not havethe disease

Meningococcal Disease

Had the di ease

Incidence100/10002,94,611,718,420,021,020,413,68,514,325,323,031,58,77,6

BlumenauCases

5821343841412818315651712018

HomeopathicMedication

Methodology

Year Santa CatarinaCases Incidence

1001100083 134 3,584 241 6,15 159 4,0

86 213 5,287 274 6,688 367 8,689 423 9,790 318 7,291 294 6,592 266 5,893 381 8,194 429 8,995 534 10,996 405 8,397 98 2,0

The medication

The Health Secretary of Blumenau stud-ied a way to fight the increase in the num-ber of cases, without using the Cuban vac-cine, as there wa not an epidemic ratethat justified a massive campaign, in-linewith the criteria from the Brazilian HealthDepartment. There was, after this, contactwith homeopath who had experience u -ing the nosode for immuni ation. Therewas experience with immunisation usingIIlellillgococcinlllll in Florianopolis andnearby towns in 1989, and the reports hadbeen ufficiently positive.After contact with the Department of theMonitoring Epidemiologist of Blumenau,they opted to initiate the immunisation onJune 9. However, one day of the campaignwas not enough, becau e the data entryfor each immuni ed per on took too muchtime. Due to popular demand, they optedto prolong the use of the medication.Thus, the campaign was extended forthree days, but it wa interrupted for oneday, which was a holiday. The medicinechosen was Meningococcilllim 30 CH, theone that several authors as Demarque, 13'!erand Eizayaga (3) consider.

Observation: a an expected value wa lesser than 5,0, Fischer Accurate Test is themo t recommendable. Population from 0 to 19 years of age, estimated for 1998.

65.82623.53989.365

Value p0,00008590,00008590,0004218

0,0005413

Qui square15,4215,4215,43

01 65.82507 23.53208 89.357

statistics of the data of the table above

Without correctionMantel-Haen zelCorrection ofYate

Fischer Accurate Test

receiveddid not receiveTotalAnaly i

A chemical preparation was from cepa,i olated in the ba is of liquor, taken out ofone of the patients, a sixteen-year-old,who died on May 07, 1988, from Timbo,neighboring city of B1umenau. Cepa wasinactivated in the Central Laboratory inFlorianopoli of the Health Departmentof Santa Catarina State and prepared bypharmaceutical a istant Andio Dias doNa cimento Junior and Fabio Jose Galvao10gueira in May, 1998. The inactivation

wa done in an autoclave at 121°C for fif-

Homceopathic Links, Winter 2001, Vol. 14 (4) 231

VACCINA TlON

Chart 3: Distribution of the population of Blumenau between 0 to 20(incomplete) years ofage as having or not received the homeopathic medication and if there was not DM in theperiod of June 12 to June 30, 1999.

Observation: As an expected value was lesser of 5,0 the accurate test of Fischer isthe most recommendable. Population from 0 to 19 years of age estimated for 1999.In the stated period of one year after the u e of the no ode the possibility ratio (oddratio) a person contracts some type of MD wa of 0,09 (variation between 0,02 and0,03) what it corresponds to a 91 % effectiveness (variation between 98 and 67%).

Homeopathic Had the disease Did not haveMedication the diseasereceived 03 65.825did not receive 13 25.045Total 16 90.870Analysis Statistics of the data of the table above

According to the record, nine cases hadobservable ide effects from the nosode.The majority presented with symptomslike chronic headache, fever and nausea.Some of these cases were controlled withNux vomica 6 CH, when assisted by ahomeopath and others with symptomaticallopathic medication. Chart 5 showsthese cases.

protection for more types of viral meningi-tis than only meningococcal meningitis.Either that, or it would have a question-able protective effect (5). Costa revised thedata of the vaccination and the register ofcases, and after considering the individu-als that did not complete the vaccination,showed that the average effectivenes ofthe vaccine was 68% (with a standardshunting line of 49 to 0%)(6).The use of Meningococcinum as prophylac-tic to meningococcal disease is not a newdevelopment in the medical homeopathicfield (12,13,14,15,16,17,18,19,20,21). Itwas used in Guaratingueni-SP, Brazil, in1974, with positive results (3). The usethat this work refers to does not charac-terise experimentation. It was an alterna-tive initiative to the use of the Cuban vac-cine which was not indicated becausethere was no rate of epidemic. The regis-ters that were made were for monitoring -the usual factor when any medicine isused on a large scale. Scientific methodol-ogy was not used because there was no in-tention to carry out an experiment or test.However, the data exists and can be

Total

65.82825.05890.886

Value p0,00000150,00000150,0000060

0,0000123

Chart 4: Meningococcal Disease confirmed Cases from January 01, 1998 uncil June 30,1999. Blumenau-SC, Brazil.

Initial of Type of Age (#) Received Case Diseasethe name disease(#) os ode Report Date BeginningLMRFS 2 4m no 01/30/98 01/28/98FDS 3 16 y no 03/30//98 03/28/98HMA 2 4m no 04/16/98 04/14/98SC 2 lly no 04/20/98 04/20/98SK 2 19 y no 05/13/98 05/12/98TAM** 2 6m no OS/21/98 OS/20/98

The Beginning of OSODE USE on September 06, 1998

SS 2 19 y no 06/19/98 06/18/98EKS 3 3m ye 07/17/98 07/17/98RK 3 15 y no 08/24/98 08/21/98KS 3 14 m no 08/24/98 08/22/98DPS 1 16 m no 09/14/98 09/13/98DLW 1 14 y no 09/23/98 09/22/98FZB 2 8y no 12/23/98 12/23/98DEC 1 5y no 01/01/99 12/31/98EKS 1 12 m yes 01/26/99 01/24/99RHS 1 7y no 01/27/99 01/26/99PHG 3 4y no 01/29/99 01/28/99LSM** 1 3y no 01/31/99 01/30/99CCH 1 2y yes 02/13/99 02/12/99MMGS** 1 2m was not born 03/07/99 03/06/99EHD 3 2y no 05/02/99 05/01/99IFC 1 2y no 05/18/99 05/18/99

(#) Age y = year m = month

Type of Meningococcal Disease(*)1 Meningoccocemia2 Meningitis Meningococcal3 Meningococcal Meningitis with Meningoccocemia

(4). There were questions concerning itefficiency, tated by J. c. Moraes. Initiallythe VA-MENGOC BC would have offered

Meningococcal Disease

Qui square23,0923,0920,48

Fischer Accurate Test

Without correctionMantel-HaenszelCorrection ofYates

munisation.

Discussion

Based in a Sierra study, where good re-sults were presented about the control ofMD in Cuba (10), in the state of SantaCatarina in 1990-1992, began indiscrimi-nate vaccination with anti-meningococcalvaccine BC (VA-MENGOC BerM) underthe ethical allegation that the everity ofthe disease and the possible protective ef-fect justified its use non-experimentally

In these six months, the possible ratio(odds ratio) for a person to contract sometype of MD was 0,05 (variation between0,00 and 0,41) which corresponds to a95% effectiveness rate (variation between100 and 59%).Chart 3 shows us that sixteen ca es ofMD happened within one year of immu-nisation; only three of these had receivedthe nosode. De pite that, the group thatwas immunised was three times largerthan the non-immunised group, and thatgroup presented four times less cases ofMD.

232 Homceopathic Links, Winter 200 I, Vol. 14 (4)

VACCI AT/O

Chart 5: Individuals that had taken the homeopathic medication and had presented reactions:

If we consider the immunisedgroup a a control, we would ex-pect about thirty-four in the im-muni ed group, if the no ode hadnot been working. Thu , after theimmuni ation, thirty-one newcases of MD and three possibledeath were prevented over oneyear (Picture 4). Therefore, therewas a strong connection betweenreceiving the homeopathic med-ication and not having meningo-coccal disease during the observedperiod. The data could indicatethat the homeopathic nosode of-fered a prolonged protection.Other tudie are necessary toconfirm this hypothe i . The po i-bility of the ob erved data beingaccidental wa 0,0000123% (ac-cording to the accuracy Test ofFischer).When we analyse the chart thatrepresents the side effects, twofacts hold our attention. First, thevery 10\1' number of regi teredca es. We cannot forget the po i-bilit), of regi tration mi take, andwill not ignore this a pecr. The factis that there were a great numberof case in the neighborhood ofthe patient who died (TAM of 6months). Was that a psychologicaleffect of the medication or someother type of collective homeo-pathic reaction till not registered?JYelistaeder made an ample walkthrough on vaccine and alterna-tive vaccine and concludes thatthere are e\'idence uggesting thathomeopathic medicine can pre-vent diseases during epidemics. Hecites the study of Castro and No-geira, 1974 during the epidemic ofmeningiti In Brazil (where

been close to the observed averagein the nineties, a shown in picture1.

There i no tru tworthy data avail-able in literature relating to howlong the protection, that the home-opathic nosode offer , la t . Cas-tro's publication present a protec-tive effect of three months (3). Butwhen analy ing the di tribution ofcases in the two groups, we ob-erve, again, that among those

who received NlellillgococcillUIII,there were fewer ca e (Picture 3),after one year.

• IrrfRlnlzed

• Non-lrrfRlnlzed

• IrrfRlnlzed• Non-lrrfRlnlzed

• IrrfRlnlzed

• Non-irrfRlnlzed

.Immunlz.d

• Non~mmunlzed

13

Picture 2

Piclllre 3

Picture 4

LocationAsilo

Fortalezaltoupava CentralItoupava Centralltoupava Centralltoupava Centralltoupava Central

Progre 0Pomerode (town)

Piclllre 1

7

3

dlatrlbution of the I11Inlngococeal disease eas•• withIrrfRlnlzed and non-irrfRlnlzed be~en June 12 andDecember 31 In 1998 If there was not IrrfRlnlzation

dlatrlbultlon of the I11Inlngococclnum disease cases withIrrfRlnlzed and non-lrrfRlnlzed be~en June 12 In 1998 and

June 30 in 1999

distribution of the menlngococc.1 dl ••••• c•••• withImmunized .nd non-Immunized betw •• n Jun. 121n 1998 .nd

Jun. 30 In 1999 If th ••.• was not Immunization

dlatrlbutlon of the I11Inlngococcal disease eases withIrrfRlnlz.d and non-irrfRlnlzed be~en June 12 and December

31 In 1998

Age12 yearsIgnored21 year10 year8 years7 year8 years8 years

29 years

ameMLOB

JMSSAEVSSlYSAPPDADF

SLFB

analy ed, as it has been published.The publication during the cam-paign reinforced the idea that itwa a medicine, not a vaccine.Thi objective was not only cor-rect relating to the nomenclature,as the principles of its productionwere several, but also to preventconfusion with vaccine on the of-ficial immunisation calendar. Forthat same rea on there was no reg-iter in the Vaccine Order.\'(Ie must point out the excellentreceptivity of the population to thecampaign. We must consider thehort time for publicity in the me-

dia and the clear contrary mani-fe tation to the initiative on thepart of the allopathic doctor - afact that was already a goal re-flected on the part of Damas( 11).This fact demon trate that home-opathy i very important to thepopulation, due to it bicentennialhistory of po itive results and therespect of the principle that guidethe process of health and disea ein a human being.Although the number of MDcases has not diminished in the sixmonths following the no ode u e,the great majority of ca es ap-peared in the group of people thatdid not receive the nosode, despiteit being a group 2,7 times less inize. (Picture 1.) If we con ider

this group as a control, we seethat, in case the nosode did not of-fer protection, nineteen ca eamong tho e who received thenosode would have appeared (Pic-ture 2). So, in 1998 alone, eigh-teen ca es of MD were prevented.\'(!hen the death rate is around 10to 12°/0, it may have prevented twodeath. Without this program,thirty-three cases of MD wouldhave occurred during the wholeyear of 1998, which would have

Homa:opathic Link, Winter 200 I, Vol. 14 (4) 233

0('

Nlenillgococcimllli was used) and the Eis-felder study which report the ca e of theuse of the Laehyrus in the prevention ofpolio during the American epidemic in thefiftie . Ei felder applied the medicine to50.000 children and only one developedpolio (which evolved without equel ofparalysis) (7).According to eu taeder, homeopathicmedicine does not cau e important ad-verse effects and in the ab ence of anothermanner of prevention, there is no reasonnot to use it (7).In all revised literature, controversies werenot found on the beneficial effect of thenosodes (14,15,16,17,18,19,20,21). Ac-cording to Edler, since the vaccination is akind of homeopathic cure in anticipation,it is explained by the extreme imilaritybetween the vaccine and it re pectivenatural infectious agent (8).According to Gama, despite the di coveryof new vaccines, there i till a long way togo before we control MD and its mecha-nism of transmis ion. either the poly-accharide vaccines nor the protein vac-

cine, that we know of, are efficient inhindering the carrier tate or immuni ingpre chool children satisfactorily, eventhough they represent an indispensableadvance (9).

Conclusion

Homeopathy, through the u e of no ode ,presents a proposal to control some infec-tious/contagious diseases. This studydemonstrates the power of this therapy bythe Meningococcal Disease Control. Theuse of Meningococcinum 30 CH in peopleunder twenty in the city of Blumenau-SC,Brazil, during a period where there wereconcern because of the increase of thenumber of ca e , demon trated a protec-tive effect, highly significant in helpingtho e who received the nosode. Thi ef-fect la ted at least one year.Each day medicine trie to improve, andthe objective i , or hould be, alway thesame: the search for well-being and im-provement in the quality of life. This prin-ciple comes forward in Hallllelllanll's workin 1 10, as the fir t phra e of the Orgallonstates: 'The physician's highest and onlycalling is to make the ick healthy, tocure, as it is called'. All types of therapeu-tics try to reach this ideal. However, thisearch i u ually isolated, impri oned inrigid principle that each cience self-im-poses, thus surpas ing the true interests ofthe people who just hope to improve fromtheir malaise. With time we expect intelli-

gence to win, and then we will ee thetherapeutic unite in the name of themost important and only physician's mis-sion.

Thankfulness

The protection offered to the populationby MeningococcinulII 30 CH was only pos-sible due to the uccessful mobilisation bythe employees of the Health Departmentin Blumenau, a well as the dedicated ef-fort of the homeopathic colleague whocame from their citie to Blumenau,demonstrating olidarity with u and con-viction to the art of cure. These colleaguesare the physicians Alllarilys de Toledo Cesar,Anconio Andrade, Margarida Maria Vieira,Paulo Vianna da Silva and Silvio Mol/o.Our sincere thank go to them.

Bibliographical ReferencesCecil RL, Bennett jC, Plum F, uxebook of,\-Iedicille, 20' edition Pgs. 1610,1615,1618,1621. W.B. aunders Company.Philadelphia - liSA. 1996.

2 Wiles, C,\1. .UallagclllclICof XCliralogic Dis-orders, Pgs 152,172,173,174. B.\lj. Lon-don. England. 1995.

3 Castro, Alfredo. A t'acilla niplice: slla apli-cafao COIIIO1l0sMio.RevHomeopatia (SaoPaulo);(l62): 12-5. jul-set, 198~.

~ Sierra, G.v. ee al. Iaceille agaillse grollp Bl\'eisseria lIIenillgieidis: proeeceioll erial alldlIIass vaceillaeioll rcsltles ill IIba. N1PHAnn. 14:195-207,1991.

5 Moraes, j.C. A vacilla allCilllellillgococicaBCde procedellcia wballa 110Brasil. Documentoenviado ao ministerio da Saude, 9 de julhode 1993.

6 Costa, Eduardo. At'aliafao da prole!;ao COIl-ferida pela vacilla allCilllcllillgococicaBC 110mado de allla Caearilla, Bra:;il, 1990 92.

Ver. Saude Publica, 30(5):460-70,1996.7 Neu taedter, Randall. The vaccillc gllide:

making an IIlformed choice. North AtlanticBooks, Berkeley, California, USA, 1996.

8 Adler, Ubiratan Cardinalli et a!. Iacilla:agressao isopaeica 011 wrahollleopaeica poramecipafao? Rev Homeopatia (Sao Paulo);59 (1):3- , Jan-mar, 199~.

9 Gama, Silvana Granado ee al. Caracceri:;a-fao epidemiologica da doellfa mellillgococicaIta area meeropoillalla do Rio de jalleiro,Brasil, 1976 a 199-1. Rev. Saude Publica, 31(3) :254-62, 1997.

10 Comissao Mi ta Brasil-Cuba. Relaeoriopara 0 Milliseerio da Qlide do Brasil -Brasilia, 7 de abril de 1993. Revisado: Ha-valla, dezembro de 1993. 1nf. Epidemio!.SUS, 3:7-32,1994.

VACCINATIO

I I Danta, FI,h'io. DesillfonltafaO e defonll<1fi'w110 t?IlSUW 1I1ed,co: a honleopatia 110 COIllt!X10

da farmacologia medica. Re\·. Bras. Educ..\\ed.; 9 (1):25-9, jan-abr 1985.

12 Costa, Roberto. Xosodios t'i'lJOSaeellllados CIlosodio-eerapta. Rev homeopatia aoPaulo);(173):3~-5, abri-jun, 1987.

13 Garfias, Heriberto. Xllet'as aporeaciollcs ac-erca dc los Ilosodes. Homeopatia Mex;(503):19-22, maio 1987.

14 Bon-Hoa, Hui. Xosodcs illlestillaies. Home-opatia (Argent.); 57(1):27-32,1992.

15 Boucinhas, jorge Cavalcanti. Plilmo alla-phylaceiC/ls. Rev homeopatia (SaoPaulo);(167):23-7 out-dez, 1985.

16 Boyson, WA. Time alld Ilosodes. j Am lnstHomeopath 59 (7):209-11, jul-aug 1966.

17 Eizayaga, Francisco X. Sabre el IISOdc Car-cillosill ,\'CISOIIell casos de la praccica. Home-opatia (Argent.); 5 (2): 135-8, 1993.

18 Gon<;alves,Neuci da Cunha. !\IIedicamclICosetioparogellicos e jisioparologicos. Rev home-opatia (Sao Paulo);(l6 ):23-26, jan-mar,19 6.

19 Griggs, \\('B. Clillical research u·ieh collfirma-eiolls of ehe lIIeeseillalIlosode SycOlic co. j AmInst Homeopath; 60 (5): 152-3, may-jun1967.

20 Thirey years os c1illical research alld cOllfirll/a-eioll of rhe lIIeeseillalllosodedyselllery co. j AmInst Homeopath; 59 (7):23 -40, jul-aug1966.

21 Pellegrino, juan Carlo. Xosodes ell eill/a,.codoerrillario hOll/eopaeico. Homeopatia (Ar-gent.); 61(~):189-91, 1996.

22 Vijno\'sky, B. Extracros de experiencia hOll/e-opatica. Homeopatia (Argent.); 59(1 ):9-15,1994.

Cleber R. L. MroninskiSpecialise Physician in Public Healeh. Profes-sor of ehe Medical Clinic Deparemem ae Uni-versil)' Fowtdaeion in BlumenauEdson Jose AdrianoSpecialise Physician in WOrk Medicine.Healeh City Secretary in BhllltenauGerson MattosHOllleopaeh , Specialist in COlllrmmiey Q/rdGeneral Medicine, Professor of ehe MedicalClinic ae tire Universiey Foundation in Blu-lIIenallRua Waldir Medeiros 122Bairro Vel/IraBlumellau89042-340Brazil

234 Homceopathic Links, Winter 2001, Vol. 14 (4)